Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. 1997

K Torii, and K Iida, and Y Miyazaki, and S Saga, and Y Kondoh, and H Taniguchi, and F Taki, and K Takagi, and M Matsuyama, and R Suzuki
Department of Internal Medicine II, Faculty of Medicine, University of Nagoya, Japan.

This study was designed to investigate possible involvement of type IV collagenolytic matrix metalloproteinases (MMPs; 72-kDa type IV collagenase [MMP-2], 92-kDa type IV collagenase [MMP-9]), and the respective specific tissue inhibitors of these MMPs (TIMP-2 and TIMP-1) in the development of adult respiratory distress syndrome (ARDS). We determined the concentrations of these enzymes in the bronchoalveolar lavage fluid (BALF) from patients with ARDS using newly developed sensitive one-step sandwich enzyme immunoassay methods. BALF obtained from the 17 patients and eight healthy volunteer control subjects were also used for the analysis of the number of the cellular component. Concentrations of the 7S portion of type IV collagen and laminin in the BALF were measured as markers of basement membrane disruption. In the BALF from the ARDS patients, the concentrations of MMP-2 (66.7 +/- 57.0 ng/ml versus < 7.0 ng/ml for controls, p < 0.01) and MMP-9 (118.0 +/- 309.3 ng/ml versus 9.0 +/- 9.5 ng/ml for controls, p < 0.05), and the specific inhibitor of MMP-9 (TIMP-1) (161.0 +/- 145.0 ng/ml versus < 50 ng/ml for controls, p < 0.01) were significantly higher compared with those for healthy control subjects. In the ARDS patients, the concentrations of MMP-2 correlated both with those of 7S collagen and laminin; MMP-9 with the concentration of 7S collagen and the number of neutrophils. These findings suggest that the increased concentration of collagenolytic MMPs in lung plays a role in the pathogenesis of ARDS.

UI MeSH Term Description Entries
D007797 Laminin Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Merosin,Glycoprotein GP-2,Laminin M,Laminin M Chain,Chain, Laminin M,Glycoprotein GP 2,M Chain, Laminin
D008297 Male Males
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005260 Female Females

Related Publications

K Torii, and K Iida, and Y Miyazaki, and S Saga, and Y Kondoh, and H Taniguchi, and F Taki, and K Takagi, and M Matsuyama, and R Suzuki
April 1992, Chest,
K Torii, and K Iida, and Y Miyazaki, and S Saga, and Y Kondoh, and H Taniguchi, and F Taki, and K Takagi, and M Matsuyama, and R Suzuki
September 1985, The American review of respiratory disease,
K Torii, and K Iida, and Y Miyazaki, and S Saga, and Y Kondoh, and H Taniguchi, and F Taki, and K Takagi, and M Matsuyama, and R Suzuki
July 1992, Clinical and experimental pharmacology & physiology,
K Torii, and K Iida, and Y Miyazaki, and S Saga, and Y Kondoh, and H Taniguchi, and F Taki, and K Takagi, and M Matsuyama, and R Suzuki
September 1985, Clinics in chest medicine,
K Torii, and K Iida, and Y Miyazaki, and S Saga, and Y Kondoh, and H Taniguchi, and F Taki, and K Takagi, and M Matsuyama, and R Suzuki
September 1993, The American review of respiratory disease,
K Torii, and K Iida, and Y Miyazaki, and S Saga, and Y Kondoh, and H Taniguchi, and F Taki, and K Takagi, and M Matsuyama, and R Suzuki
May 1996, Nihon Kyobu Shikkan Gakkai zasshi,
K Torii, and K Iida, and Y Miyazaki, and S Saga, and Y Kondoh, and H Taniguchi, and F Taki, and K Takagi, and M Matsuyama, and R Suzuki
February 1992, The American journal of physiology,
K Torii, and K Iida, and Y Miyazaki, and S Saga, and Y Kondoh, and H Taniguchi, and F Taki, and K Takagi, and M Matsuyama, and R Suzuki
July 2004, Life sciences,
K Torii, and K Iida, and Y Miyazaki, and S Saga, and Y Kondoh, and H Taniguchi, and F Taki, and K Takagi, and M Matsuyama, and R Suzuki
August 1989, Nihon Kyobu Shikkan Gakkai zasshi,
K Torii, and K Iida, and Y Miyazaki, and S Saga, and Y Kondoh, and H Taniguchi, and F Taki, and K Takagi, and M Matsuyama, and R Suzuki
October 2001, Critical care medicine,
Copied contents to your clipboard!